Acceso abierto

Future Biotechnology

Munis Dundar

Munis Dundar

Department of Medical Genetics, Faculty of Medicine, Erciyes UniversityKayseri, Turkey
Buscar este autor en
Sciendo|Google Scholar
Dundar, Munis
, 
Satya Prakash

Satya Prakash

Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering, Faculty of Medicine, McGill UniversityMontreal, Canada
Buscar este autor en
Sciendo|Google Scholar
Prakash, Satya
, 
Ratnesh Lal

Ratnesh Lal

University of California San Diego, Jacobs School of EngineeringSan Diego, U.S.A
Buscar este autor en
Sciendo|Google Scholar
Lal, Ratnesh
 y 
Donald K. Martin

Donald K. Martin

University Grenoble Alpes, SyNaBi, TIMCIMAG/CNRS/INSERM, UMRGrenoble, France
Buscar este autor en
Sciendo|Google Scholar
Martin, Donald K.
  
24 abr 2019
Future Biotechnology's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Descargar portada
Categoría del artículo: Review
Publicado en línea: 24 abr 2019
Páginas: 53 - 56
DOI: https://doi.org/10.2478/ebtj-2019-0006
Palabras clave
© 2019 Munis Dundar, Satya Prakash, Ratnesh Lal, Donald K. Martin, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Figure 1

Overview of the human genome. Gene and gene-related sequences cover 37.5% of the human genome, while genome-wide repeats constitute 43.75%. The remaining 18.75% are intergenic regions.
Overview of the human genome. Gene and gene-related sequences cover 37.5% of the human genome, while genome-wide repeats constitute 43.75%. The remaining 18.75% are intergenic regions.

Figure 2

Examples of symbio-bots (A–D) that can be created in a bioinspired way (E). Each device is separated with a smart porous packaging that allows a duplex communication. Therapeutic cells (A and B) need a porous encapsulation that avoids an immune reaction and allows protection from both sides. They may be human cells, as MSC or specialized cells such as β-cell from Langherans islets (A), or other eukaryotic or prokaryotic cells (B). Panel C shows an IBFC linked to an electronic medical device. Panel D shows a generic device delivering a therapeutic molecule. Panel E: Existing symbiosis (i.e., microbiota or pregnancy) are a source of bio-inspiration to establish a duplex communication between the body and its implants. Regenerative medicine should embrace this concept of bioinspiration for a better design and integration of implants, especially for future symbio-bots. (reproduced with permission from Alcaraz et al (10)).
Examples of symbio-bots (A–D) that can be created in a bioinspired way (E). Each device is separated with a smart porous packaging that allows a duplex communication. Therapeutic cells (A and B) need a porous encapsulation that avoids an immune reaction and allows protection from both sides. They may be human cells, as MSC or specialized cells such as β-cell from Langherans islets (A), or other eukaryotic or prokaryotic cells (B). Panel C shows an IBFC linked to an electronic medical device. Panel D shows a generic device delivering a therapeutic molecule. Panel E: Existing symbiosis (i.e., microbiota or pregnancy) are a source of bio-inspiration to establish a duplex communication between the body and its implants. Regenerative medicine should embrace this concept of bioinspiration for a better design and integration of implants, especially for future symbio-bots. (reproduced with permission from Alcaraz et al (10)).
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Ciencias de la vida, Genética, Biotecnología, Bioinformática, Ciencias de la vida, otros
RSS Feed de revista